The gammaCore vagus nerve stimulator costs approximately $500-$600 per month in the United States without insurance coverage. It is a prescription-only, FDA-cleared non-invasive vagus nerve stimulation (nVNS) device — the only one with regulatory clearance for treating specific headache conditions. Understanding the cost structure, insurance pathways, and how gammaCore compares financially to other treatment options is essential for anyone considering it.
Cost Structure
gammaCore operates on a subscription-like model rather than a single purchase. Each device unit is pre-loaded with a set number of stimulations and expires after a defined period (typically one month). Patients receive new units on an ongoing basis through their prescriber. This model means the cost is recurring rather than a one-time investment.
The approximate out-of-pocket cost without insurance is $500-$600 per month, though the exact price can vary by pharmacy, region, and any manufacturer discount programmes in effect. For patients paying out of pocket over the long term, this represents a significant ongoing expense — approximately $6,000-$7,200 per year.
Insurance Coverage
gammaCore is covered by many commercial insurance plans and by Medicare for its FDA-cleared indications: acute treatment of episodic cluster headache, prevention of cluster headache, acute treatment of migraine, and adjunctive treatment of medication-overuse headache. Coverage approval typically requires prior authorisation and may require documentation of failed or insufficient response to other treatments.
With insurance coverage, out-of-pocket costs are substantially reduced — often to a standard specialty device copay. electroCore (the manufacturer) offers a patient assistance programme and copay assistance cards that can further reduce costs for eligible patients. The company’s patient services team can help navigate insurance authorisation and provide information about financial assistance.
Coverage for off-label uses (using gammaCore for conditions other than the FDA-cleared indications) is generally not available through insurance, meaning that patients using gammaCore for anxiety, PTSD, or general vagal support would need to pay out of pocket at the full monthly cost.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Clinician-applied tVNS
- Implanted VNS and neuromodulation
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
How gammaCore Compares Financially
vs Implantable VNS
The LivaNova implantable VNS system costs $20,000-$40,000 for the device and implantation surgery, plus ongoing costs for battery replacement (typically every 3-5 years) and follow-up programming visits. For patients with severe, treatment-resistant epilepsy or depression — the conditions for which implantable VNS is indicated — insurance typically covers most of the cost. gammaCore is substantially less expensive in the first year and does not require surgery, but the cumulative cost over several years of use approaches the one-time cost of an implant.
vs Consumer taVNS Devices
Consumer transcutaneous auricular VNS devices (Nurosym, Pulsetto, Truvaga) are one-time purchases ranging from $250-$600 with no ongoing subscription costs. Financially, they are significantly less expensive than gammaCore over any period longer than one month. However, they are not FDA-cleared for treating specific medical conditions, do not require a prescription, and have less clinical evidence than gammaCore. For patients with insurance-covered headache conditions, gammaCore with insurance may actually cost less per month than the out-of-pocket purchase of a consumer device when amortised over the device’s lifespan.
vs Medications
For migraine and cluster headache, gammaCore competes with triptans ($10-$300 per month depending on the specific drug, frequency of use, and insurance), CGRP monoclonal antibodies ($600-$700 per month before insurance), and preventive medications (topiramate, propranolol, verapamil — generally $10-$50 per month with insurance). gammaCore may be cost-competitive with CGRP antibodies and high-frequency triptan use, and more expensive than generic preventive medications.
Getting a Prescription
gammaCore requires a prescription from a physician. In practice, neurologists and headache specialists are the most common prescribers. The prescribing process involves diagnosis of a qualifying condition (cluster headache, migraine, or medication-overuse headache), documentation that the condition meets clinical criteria, insurance prior authorisation (if using insurance), and enrollment through the gammaCore patient services programme.
electroCore provides a prescriber locator and patient support resources through their website. Many headache clinics are already familiar with the device and can streamline the prescribing and authorisation process. For a broader review of VNS devices including gammaCore, see our article on the best vagus nerve stimulation devices.
Is It Worth the Cost
The value proposition of gammaCore depends on three factors: the severity of the condition being treated (patients with frequent, debilitating cluster headache or migraine who have failed other treatments may find substantial value), the availability of insurance coverage (which can reduce the effective cost dramatically), and the response to treatment (clinical trials show approximately 30-35 percent of migraine patients and 34 percent of cluster headache patients achieve a meaningful response). Not everyone responds, and there is currently no reliable way to predict who will.
A reasonable approach is to trial the device for 2-3 months (many prescribers recommend this timeline to assess response) and evaluate whether the benefit justifies the ongoing cost. electroCore has periodically offered trial programmes that reduce the financial barrier to initial assessment.
Understanding your options — devices, techniques, and lifestyle strategies — is the foundation of effective vagal health management. My Vagus Nerve & Me covers the full spectrum of approaches to vagus nerve stimulation, from free breathing techniques to clinical devices. Get My Vagus Nerve & Me eBook and make an informed choice about your vagal health.
